Strategic Acquisition Potential opportunity to engage Abbott post-acquisition for integration of CSI’s atherectomy technology with Abbott’s broader cardiovascular device portfolio and distribution channels.

Scale Gap With a small team and revenue under one million, there is likely a need for scalable solutions, services, and partnerships to support growth, field support, and manufacturing capabilities.

Clinical Proof Emphasize solutions that enhance clinical outcomes, data analytics, and post-market surveillance to align with CSI’s focus on unparalleled clinical proof and arterial calcium treatment.

Channel Expansion Leverage existing relationships with large OEMs and distributors in medical devices to co-sell or embed technology, potentially accelerating market reach for thrombectomy and atherectomy offerings.

Technology Stack Fit Offer cloud, analytics, and security solutions that integrate with CSI’s tech stack ( Google Cloud, SAP, Microsoft platforms, Marketo ) to streamline operations, data capture, and regulatory compliance during scale.